Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

Jordan Gauthier,Luca Castagna,Federico Garnier,T Guillaume,Gérard Socié,Sébastien Maury,N Maillard,Reza Tabrizi,Tony Marchand,Jean-Valère Malfuson,Anne-Claire Gac,Emmanuel Gyan,M. Mercier,Yves Beguin,Jeremy Delage,Pascal Turlure,Ambroise Marçais,S Nguyen,Remy Dulery,J. O. Bay,Anne Huynh,Etienne Daguindau,Jérôme Cornillon,C Régny,Mauricette Michallet,R. Peffault de Latour,Ibrahim Yakoub-Agha,Didier Blaise

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

2017

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

Keywords:

Lymphoma
Immunology
Bone marrow
Progenitor cell
Medicine
Graft-versus-host disease
Transplantation
Cell therapy
Stem cell
Human leukocyte antigen
Cord blood
Hazard ratio
Cyclophosphamide
Transplantation Conditioning
Histocompatibility
Cord Blood Stem Cell Transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations